Description
An antiviral nucleoside analog; metabolized to an active triphosphate form that induces viral chain termination and inhibits viral polymerases; reduces replication in a panel of seven RNA and four DNA viruses in Vero cells (EC50s = 2-95 µg/ml); reduces replication of SARS-CoV-2 in Vero cells (EC50 = 109.5 µM); aerosol administration reduces mortality in a mouse model of influenza A infection at 30 mg/kg
Formal name: 1-β-D-ribofuranosyl-1H-1,2,4-triazole-3-carboxamide
Synonyms: NSC 163039
Molecular weight: 244.2
CAS: 36791-04-5
Purity: ≥95%
Formulation: A crystalline solid
Product Type|Biochemicals|Antivirals|DNA & RNA Polymerase Inhibitors||Product Type|Biochemicals|Nucleotides/Nucleosides||Research Area|Immunology & Inflammation|Pulmonary Diseases|COVID-19||Research Area|Infectious Disease|Viral Diseases|Coronaviruses||Research Area|Infectious Disease|Viral Diseases|Hepatitis||Research Area|Infectious Disease|Viral Diseases|Influenza||Research Area|Infectious Disease|Viral Diseases|RSV Infections